Mollie Barnes

Nummular eczema and ringworm look very similar, and it can be very difficult for the average person to distinguish it. “Even a general doctor without an expertise in dermatology can have a hard time spotting the subtle differences,” said dermatologist Dr. Benjamin Ungar.

This latest edition of Ask the Ecz-perts focuses on how people of every gender can handle eczema on sensitive areas such as the nipples and genitals. Our expert discusses how to handle itching, what lotions and medications you can use and precautions you can take to prevent flares in these areas.

It's been nearly four months since the FDA's historic Dec. 8, 2023 dual approvals of Vertex-CRISPR's hashtag#Casgevy and bluebird bio's hashtag#Lyfgenia, the first cell-based hashtag#genetherapies approved for hashtag#sicklecelldisease. How are the rollouts of these expensive treatments going? And which one will emerge as the victor?

The grant will allow him to expand his research at the USC Caruso Department of Otolaryngology Head and Neck Surgery on the role of outer hair cells in normal hearing.

Staffing agencies say contract work is a great way to break into an industry and avoid a resume gap.

Baisong Mei is no stranger to leadership roles. At just 15 years old, he was already in medical school leading a group of students 10 years his senior.

For Paul Bresge, getting into biotech wasn’t fulfilling a career goal. It was fulfilling a promise.

The handful of biotechs that went public in 2023 fared well, providing hope to a cautiously optimistic sector.

The Interface Biosciences co-founder said forging the relationships needed to launch a startup can be a challenge for members of underrepresented groups, making confidence and adaptability key.

In this edition of Ask the Ecz-perts, we get the lowdown on how people with eczema can care for hypopigmentation, which is light spots of the skin. Our experts talk about causes of the light spots and how you can treat them.

It’s been a difficult year for biopharma, with many companies doing rounds of layoffs, a parched investment climate for startups and multiple bankruptcies. When these things happen to you, it’s hard not to take them personally or view them as a failure.

A study finds that employees are more likely to view pay for performance positively—and rise to the challenge of performing well—when they view their managers as friendly and good at their jobs.

With Amgen’s Lumakras and Mirati’s Krazati already approved for the second-line treatment of KRAS-mutated non-small cell lung cancer, the longtime competitors—along with newer contenders—are vying to bring the first KRAS inhibitor to the frontline.

For Ido Badash, MD, the key for medical students to finding success in residency is to choose a place where one can see themselves thriving with plenty of opportunities to reach one’s full potential.

The biopharma industry is moving toward AI to try to determine how well a person would perform in a role, with applications that go beyond recruiting.